Css LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $1.82 Million - $3.84 Million	56,300 New	56,300 $3.83 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $941,250 - $1.59 Million	-25,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $247,972 - $350,103	4,700 Added 23.15%	25,000 $1.38 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $989,218 - $1.66 Million	20,300 New	20,300 $1.28 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.